<DOC>
	<DOCNO>NCT00594464</DOCNO>
	<brief_summary>Evaluation efficacy safety use rotigotine patient suffer Parkinson 's Disease surgery require general anaesthesia .</brief_summary>
	<brief_title>A Trial Neupro® ( Rotigotine Transdermal Patch ) Patients With Parkinson 's Disease Undergoing Surgery</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>N 0437</mesh_term>
	<criteria>Subject idiopathic Parkinson 's disease ( early advancedstage ) , define cardinal sign bradykinesia , plus presence least one following : rest tremor , rigidity , postural instability without know suspected cause Parkinsonism . Subject schedule operation require general anesthesia . Subject previously treat rotigotine . Subject history significant skin hypersensitivity adhesive transdermals recent unresolved contact dermatitis know allergy hypersensitivity rotigotine component patch . Subject schedule surgical procedure ( surgery per protocol ( SPP ) ) require magnetic resonance image cardioversion . Subject high probability require extend postoperative ventilation ( &gt; 24 hour ) . Subject medical condition , opinion investigator , could jeopardize compromise subject 's ability participate trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Rotigotine</keyword>
	<keyword>NEUPRO®</keyword>
	<keyword>Parkinson 's Disease ( PD )</keyword>
	<keyword>perioperative use</keyword>
	<keyword>anaesthesia ,</keyword>
</DOC>